Nexium Capsules LDA Specific Clinical Experience Investigation
NCT01729182 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2363
Last updated 2019-08-07
Summary
The purpose of this investigation is to collect following data in patients given Nexium capsule (Nexium) for long term in usual-post-marketing therapy to prevention of recurrence of gastric ulcer or duodenal ulcer with Low dose Aspirin (LDA).
Conditions
- Gastric Ulcer
- Duodenal Ulcer
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Shigeru Yoshida, MD · AstraZeneca
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-01-01
- Primary Completion
- 2017-03-09
- Completion
- 2017-03-09
Countries
- Japan
Study Locations
More Related Trials
-
A Safety and Efficacy Study of Lansoprazole in Preventing Aspirin-Induced Gastric and Duodenal Ulcers
NCT00762359 ·Status: TERMINATED ·Phase: PHASE3
-
A Unblinded Study of TAK-438 (20 mg) for Prevention of Recurrence of Gastric or Duodenal Ulcer During Long-Term Low-Dose Aspirin Therapy
NCT01568398 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of TAK-438 for the Prevention of Recurrent Gastric or Duodenal Ulcers During Therapy of Low-dose Aspirin
NCT01452763 ·Status: COMPLETED ·Phase: PHASE3
-
Long Term Study to Investigate the Efficacy & Safety of D961H (Esomeprazole) for the Prevention of NSAIDs-induced Ulcer
NCT00595517 ·Status: COMPLETED ·Phase: PHASE3
-
Long-term Extension Study of TAK-438 for the Prevention of Recurrent Gastric or Duodenal Ulcers During Therapy of Non-steroidal Anti-inflammatory Drug (NSAID)
NCT01456260 ·Status: COMPLETED ·Phase: PHASE3
-
Comparative Efficacy & Safety Study of D961H Versus Placebo for the Prevention of Gastric and Duodenal Ulcers With Low-dose Aspirin
NCT01069939 ·Status: COMPLETED ·Phase: PHASE3
-
Long-term Extension Study of TAK-438 for the Prevention of Recurrent Gastric or Duodenal Ulcers During Therapy of Low-dose Aspirin
NCT01456247 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Lansoprazole on Gastric and Duodenal Ulcers in Patients Taking Nonsteroidal Anti-Inflammatory Drugs
NCT00787254 ·Status: COMPLETED ·Phase: PHASE3
-
ASTERIX: Low Dose ASA and Nexium
NCT00251966 ·Status: COMPLETED ·Phase: PHASE3
-
A Unblinded Study of TAK-438 (20 mg) for Prevention of Recurrence of Gastric or Duodenal Ulcer During Long-Term Non-Steroid Anti-Inflammatory Drug (NSAID) Therapy
NCT01568385 ·Status: COMPLETED ·Phase: PHASE3
-
Long-term Use of Takepron on the Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Non-steroidal Anti-inflammatory Drugs
NCT02099708 ·Status: COMPLETED
-
A Comparative Efficacy and Safety Study of Nexium Delayed-Release Capsules (40mg qd and 20mg qd) Versus Ranitidine 150mg Bid for the Healing of NSAID-Associated Gastric Ulcers When Daily NSAID Use is Continued in Subjects in the US Only
NCT00633412 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of TAK-438 for the Prevention of Recurrent Gastric or Duodenal Ulcers During Therapy of Non-steroidal Anti-inflammatory Drug (NSAID)
NCT01452750 ·Status: COMPLETED ·Phase: PHASE3
-
S-CEI of Nexium in Paediatric Patients
NCT03562026 ·Status: COMPLETED
-
A Study to Investigate the Pharmacodynamic Effect After Four-week Omeprazole Treatment of Non-erosive Reflux Disease in a Japanese Population
NCT00259051 ·Status: COMPLETED ·Phase: PHASE3
-
Drug Interaction Study Between AZD3355 and Nexium
NCT00684190 ·Status: COMPLETED ·Phase: PHASE1
-
Nexium Dyspepsia/AST
NCT00251992 ·Status: COMPLETED ·Phase: PHASE3
-
A Comparative Efficacy and Safety Study of Nexium Delayed-Release Capsules (40mg qd and 20mg qd) Versus Ranitidine 150mg Bid for the Healing of NSAID-Associated Gastric Ulcers When Daily NSAID Use is Continued
NCT00633672 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Compare PK, PD and Safety of CKD-381 in Healthy Subjects
NCT03211143 ·Status: COMPLETED ·Phase: PHASE1
-
Adult Asthmatics and Acid Reflux
NCT00628953 ·Status: COMPLETED ·Phase: PHASE2
-
Endoscopic Evidence of Maintenance of Healing With Oral NEXIUM in Patients 1 to 11 Years Old With Erosive Esophagitis.
NCT05267613 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Nexium Dyspepsia/AST
NCT00251914 ·Status: COMPLETED ·Phase: PHASE3
-
Rabeprazole Specific Clinical Experience Investigation for the Long-term Combination Therapy With Low-dose Aspirin
NCT02423187 ·Status: COMPLETED
-
Special Drug Use Surveillance of Vonoprazan for "Prevention of Recurrence of Gastric/Duodenal Ulcer in Patients Receiving Non-steroidal Anti-inflammatory Drugs: Long-term Use"
NCT03214198 ·Status: COMPLETED
-
Comparative Efficacy & Safety Study of Esomeprazole Versus Placebo for the Prevention of Gastric and Duodenal Ulcers With NSAID
NCT00542789 ·Status: COMPLETED ·Phase: PHASE3